Neuropathological examination of fetal rat brain in the 5-bromo-2′-deoxyuridine-induced neurodevelopmental disorder model

Congenital Anomalies

Volumn 45, Issue 1, 2005, Pages 14-20

  Ogawa, Tetsuo ^a   Kuwagata, Makiko ^a   Muneoka, Katsumasa T ^a   Shioda, Seiji ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

BrdU; Developmental neurotoxicity; Neurodevelopmental disorder; Neuropathology

Indexed keywords

BROXURIDINE; MICROTUBULE ASSOCIATED PROTEIN 2; MICROTUBULE ASSOCIATED PROTEIN; MTAP2 PROTEIN, RAT; TERATOGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL DEATH; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EXPERIMENTAL MODEL; FETUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOCOMOTION; NEOCORTEX; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CONGENITAL MALFORMATION; DISEASE MODEL; DRUG EFFECT; FEMALE; MALE; METABOLISM; PATHOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; SPRAGUE DAWLEY RAT;

ANIMALIA;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; BRAIN; BROMODEOXYURIDINE; CELL DEATH; DISEASE MODELS, ANIMAL; FEMALE; FETUS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TERATOGENS;

EID: 21344442599     PISSN: 09143505     EISSN: 17414520     Source Type: Journal    
DOI: 10.1111/j.1741-4520.2005.00055.x     Document Type: Article

References (35)

1. Anderson SA, Marin O, Horn C, Jennings K, Rubenstein JL (2001) Distinct cortical migrations from the medial and lateral ganglionic eminences. Development 128: 353-363.
2. Biggers WJ, Barnea ER, Sanyal MK (1987) Anomalous neural differentiation induced by 5-bromo-2′-deoxyuridine during organogenesis in the rat. Teratology 35: 63-75.
3. Burd L, Klug MG, Martsolf JT, Kerbeshian J (2003) Fetal alcohol syndrome: Neuropsychiatrie phenomics. Neurotoxicol Teratol 25: 697-705.
4. Erlandsson A, Enarsson M, Forsberg-Nilsson K (2001) Immature neurons from CNS stem cells proliferate in response to platelet-derived growth factor. J Neurosci 21: 3483-3491.
5. Ferreira A, Busciglio J, Caceres A (1987) An immunocytochemical analysis of the ontogeny of the microtubule-associated proteins MAP-2 and Tau in the nervous system of the rat. Brain Res Dev Brain Res 431: 9-31.
6. Fujimori K, Takauji R, Tamamaki N (2002) Differential localization of high- and low-molecular-weight variants of microtubule-associated protein 2 in the developing rat telencephalon. J Comp Neurol 449: 330-342.
7. Greene LA, Liem RK, Shelanski ML (1983) Regulation of a high molecular weight microtubule-associated protein in PC12 cells by nerve growth factor. J Cell Biol 96: 76-83.
8. Hsu FC, Zhang GJ, Raol YS, Valentino RJ, Coulter DA, Brooks-Kayal AR (2003) Repeated neonatal handling with maternal separation permanently alters hippocampal GABAA receptors and behavioral stress responses. Proc Natl Acad Sci USA 100: 12213-12218.
9. Izant JG, McIntosh JR (1980) Microtubule-associated proteins: A monoclonal antibody to MAP2 binds to differentiated neurons. Proc Natl Acad Sci USA 77: 4741-4745.
10. Jacobson JL, Jacobson SW (1996) Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med 335: 783-789.
11. Kuwagata M, Nagao T (1998) Behavior and reproductive function of rat male offspring treated prenatally with 5-bromo-2′-deoxyuridine. Reprod Toxicol 12: 541-549.
12. Kuwagata M, Saito Y, Usumi K, Ono H, Nagao T (2001) Disruption of brain development in male rats exposed prenatally to 5-bromo-2′-deoxyuridine. Cong Anom 41: 312-320.
13. Kuwagata M, Muneoka KT, Ogawa T, Takigawa M, Nagao T (2004) Locomotor hyperactivity following prenatal exposure to 5-bromo-2′-deoxyuridine: Neurochemical and behavioral evidence of dopaminergic and serotonergic alterations. Toxicol Lett 152: 63-71.
14. Lehmann J, Stohr T, Feldon J (2000) Long-term effects of prenatal stress experiences and postnatal maternal separation on emotionality and attentional processes. Behav Brain Res 107: 133-144.
15. Lindvall O, McKay R (2003) Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci USA 100: 7925-7930.
16. Marin O, Rubenstein JL (2003) Cell migration in the forebrain. Annu Rev Neurosci 26: 441-483.
17. Miller MW, Nowakowski RS (1988) Use of bromodeoxyuridine- immunohistochemistry to examine the proliferation, migration and time of origin of cells in the central nervous system. Brain Res 457: 44-52.
18. Moore SJ, Turnpenny P, Quinn A et al. (2000) A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 37: 489-497.
19. Morris SM (1991) The genetic toxicology of 5-bromodeoxyuridine in mammalian cells. Mutat Res 258: 161-188.
20. Murphy ML (1965) Dose-response relationships in growth-inhibitory drugs in the rats, time of treatment as a teratological determinant. In: Wilson JG, Warkany J (eds). Teratology, Principles and Techniques. University of Chicago Press, Chicago, pp. 161-184.
21. Nagao T, Saito Y, Watanabe C, Imai K (1997) Reproductive effects of prenatal exposure to 5-bromo-2′-deoxyuridine on male rats. Reprod Toxicol 11: 37-45.
22. Nagao T, Kuwagata M, Saito Y (1998) Effects of prenatal exposure to 5-bromo-2′-deoxyuridine on the developing brain and reproductive function in male mouse offspring. Reprod Toxicol 12: 477-487.
23. Ogawa T, Mikuni M, Kuroda Y, Muneoka K, Mori KJ, Takahashi K (1994) Periodic maternal deprivation alters stress response in adult offspring: potentiates the negative feedback regulation of restraint stress-induced adrenocortical response and reduces the frequencies of open field-induced behaviors. Pharmacol Biochem Behav 49: 961-967.
24. Rogan WJ, Gladen BC, Hung KL et al. (1988) Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science 241: 334-336.
25. Ruffolo P, Ferm V (1965) The embryocidal and teratogenic effects of 5-bromodeoxyuridine in the pregnant hamster. Lab Invest 14: 1547-1553.
26. Schwartz SA, Kirsten WH (1974) Distribution of 5-bromodeoxyuridine in the DNA of rat embryo cells. Proc Natl Acad Sci USA 71: 3570-3574.
27. Skalko RG, Packard DS, Schwendiman RN, Raggio JF (1971) The teratogenic response of mouse embryos to 5-bromodeoxyuridine. Teratology 4: 87-94.
28. Soriano E, Del Rio JA (1991) Simultaneous immunocytochemical visualization of bromodeoxyuridine and neural tissue antigens. J Histochem Cytochem 39: 255-263.
29. Takahashi T, Goto T, Miyama S, Nowakowski RS, Caviness VS Jr (1999) Sequence of neuron origin and neocortical laminar fate: Relation to cell cycle of origin in the developing murine cerebral wall. J Neurosci 19: 10357-10371.
30. Tamamaki N, Fujimori KE, Takauji R (1997) Origin and route of tangentially migrating neurons in the developing neocortical intermediate zone. J Neurosci 17: 8313-8323.
31. Webster W, Shimada M, Langman J (1973) Effect of fluorodeoxyuridine, colcemid, and bromodeoxyuridine on developing neocortex of the mouse. Am J Anat 137: 67-85.
32. Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH (2001) Fetal valproate syndrome and autism: Additional evidence of an association. Dev Med Child Neurol 43: 202-206.
33. Yamauchi H, Katayama K, Ueno M, Uetsuka K, Nakayama H, Doi K (2004) Involvement of p53 in 1-beta-D-arabinofuranosylcytosine-induced rat fetal brain lesions. Neurotoxicol Teratol 26: 579-586.
34. Yu WH (1976) The effect of 5-bromodeoxyuridine on the postnatal development of the rat cerebellum: A biochemical study. Brain Res 118: 281-291.
35. Yu WH (1977) The effect of 5-bromodeoxyuridine on the postnatal development of the rat cerebellum: morphologic and radioautographic studies. Am J Anat 150: 89-107.